Innoforce

News & Events

Innoforce Opens GMP Manufacturing Facility & Corporate Headquarters in Hangzhou, China to Provide CDMO Services for Global Supply of RNA, Cell & Gene Therapies

The new site adds to its capacity in China & US to provide end-to-end process development and global manufacturing services for advanced therapies

Innoforce, Mayo Clinic & Hibiscus BioVentures launch Mayflower BioVentures

Innoforce and Hibiscus BioVentures Announce Strategic Partnership

Innoforce Completes Second Tranche of Series A Financing

Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China

Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing

Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics

01
02
03

keywords：mRNA CDMO mRNA CDMO